Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about MDMA/assisted therapy
Recent news which mentions MDMA/assisted therapy
PharmAla Biotech To Supply University Of Texas, San Antonio For Clinical Trial
October 08, 2024
Tickers
MDMA
MDXXF
NEWS
Tags
News
Nicholas Kadysh
Harpeet Kaur
From
Benzinga
Sam Altman's Psychedelic Breakthrough: How The OpenAI Visionary Plans To Transform Mental Health Care With MDMA
September 25, 2024
Tickers
NEWS
TSLA
Tags
Sam Altman
Top Stories
Psychedelic Assisted Therapies
From
Benzinga
MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?
September 12, 2024
Tickers
ATAI
CMPS
DMT
MBIO
Tags
CMPS
Psylocibin
News
From
Benzinga
Multidisciplinary Association For Psychedelic Studies Eyes State-Level Legalization After FDA Denial Of MDMA Therapy
September 11, 2024
Tickers
MDMA
NEWS
Tags
Betty Aldworth
Darron Smith
MDMA
From
Benzinga
Drug Science Research Group And London College Team Up To Advance MDMA-Assisted Therapy
September 04, 2024
Tickers
MDMA
NEWS
Tags
David Nutt
News
MDMA PTSD
From
Benzinga
Multidisciplinary Association For Psychedelic Studies Funds MDMA-Assisted Therapy Trial For PTSD
August 29, 2024
Tickers
MDMA
NEWS
Tags
MDMA/assisted therapy
Benzinga
Cannabis
From
Benzinga
Lykos Therapeutics Strategic Reorganization Following FDA's Decision Rejecting MDMA For PTSD Treatment
August 16, 2024
Tickers
NEWS
Tags
Benzinga
MDMA/assisted therapy
Market News
From
Benzinga
MDMA Therapy Papers Retracted Amid Ethical Concerns At Lykos Study Site
August 13, 2024
Tags
Lykos Therapeutics
Food and Drug Administration
Psychedelics
From
Benzinga
Five Out Of Six Studies On MDMA Show Positive Results, Yet FDA Approval Still Faces Hurdles
August 07, 2024
Tickers
NEWS
Tags
Health Care
Psychedelics
Lykos Therapeutics
From
Benzinga
Art Installation Near White House Urges FDA To Approve MDMA-Assisted Therapy For Veterans As Decision Time Looms
July 29, 2024
Tickers
NEWS
Tags
Benzinga
FDA
MDMA/assisted therapy
From
Benzinga
Two Top Biotechs Forge MDMA Supply Deals For Clinical Research
March 26, 2024
Tickers
MDXXF
NEWS
NUMIF
OPTHF
Tags
News
Tel Aviv University
Psychedelics Research
From
Benzinga
Atai Life Sciences Shows Positive Results In Phase 1 Clinical Study For PTSD Treatment
January 04, 2024
Tickers
ATAI
NEWS
Tags
Psychedelics
R/MDMA
Biotech
From
Benzinga
Could MDMA Revolutionize PTSD Treatment? In Historic Move, FDA Considers New Drug Application
December 12, 2023
Tags
News
Regulations
MAPS PBC
From
Benzinga
Canadian Practitioners Can Now Enroll In MDMA-Assisted Psychotherapy Training Program
September 25, 2023
Tags
MDMA/assisted therapy
TheraPsil
Psychedelics Therapy Training
From
Benzinga
Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News
September 15, 2023
Tickers
NUMIF
Tags
Multidisciplinary Association for Psychedelic Studies
Management
Legal
From
Benzinga
Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next
September 14, 2023
Tags
Market News
Cannabis
Markets
From
Benzinga
Fluence Inks Deal To Bring Brazil's Psychedelic Therapy Training Scene To New Heights
July 26, 2023
Tags
News
Psychedelic/Assisted Therapy Training
Management
From
Benzinga
MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University
June 20, 2023
Tickers
NUMIF
OPTHF
PMBHF
Tags
OPTHF
News
PMBHF
From
Benzinga
Numinus Partners With MAPS To Conduct Phase 1 MDMA Assisted Therapy Investigational Study
June 16, 2023
Tickers
MAPS
NUMIF
Tags
Psychedelics
Health Care
Cannabis
From
Benzinga
Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia
June 12, 2023
Tickers
PMBHF
Tags
Market News
Cannabis
Penny Stocks
From
Benzinga
Creso Pharma's LOI For Import Of Swiss MDMA And Psilocybin Therapeutics To Australia
June 09, 2023
Tickers
COPHF
MNMD
Tags
News
MNMD
Markets
From
Benzinga
EXCLUSIVE: MDMA Therapy Experts Debate Upcoming Approval And Psychedelic Market Opps
April 19, 2023
Tickers
AWKNF
Tags
Financing
Psychedelics Investing
MDMA/assisted therapy
From
Benzinga
Two Psychedelics Companies Collaborate To Provide Clinical-Grade MDMA Capsules For Authorized Patients And Studies
April 11, 2023
Tickers
FLHLF
Tags
Cannabis
Market News
MDMA/assisted therapy
From
Benzinga
MDMA Transdermal Patch Moves Toward First-In-Human Trials: Latest Development Update
April 03, 2023
Tickers
PHRRF
RVVTF
Tags
Markets
RVVTF
News
From
Benzinga
MDMA News: Exclusive Supply Deal With Awakn Life Sciences & Canadian Company Expands Psychedelics Production
March 02, 2023
Tickers
AWKNF
Tags
Psychedelics
AWKNF
Controlled Substances Act
From
Benzinga
Australia's Psychedelics Therapy Provides Hope For Treatment-Resistant Mental Health Conditions
February 07, 2023
Tickers
NUMIF
Tags
Markets
Psilocybin/Assisted Therapy
Legal
From
Benzinga
Psyched: Australia Legalizes Psychedelics Therapy, BC's Decrim, State Bills, Millions For Trials & Clinics
February 06, 2023
Tickers
IWINF
ORIG
PHRRF
PSIL
Tags
MDMA/assisted therapy
Benzinga
Cannabis
From
Benzinga
MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations
February 06, 2023
Tickers
OPTHF
PHRRF
RVVTF
Tags
Psychedelics Investing
PHRRF
Market News
From
Benzinga
MDMA Therapy For Chronic PTSD: Neuroimaging With Veterans & First Responders Provides Further Evidence
January 23, 2023
Tags
Market News
Markets
Cannabis
From
Benzinga
Psyched: NY Discusses Regulations, MDMA For PTSD Aims For Legalization, Shrooms For Eating Disorders & More
January 10, 2023
Tickers
PSIL
PSYK
TRYPF
Tags
eating disorders
Management
Legal
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.